Autumn Glory Partners LLC Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Autumn Glory Partners LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 51.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 890 shares of the medical equipment provider’s stock after selling 944 shares during the period. Autumn Glory Partners LLC’s holdings in Intuitive Surgical were worth $465,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ISRG shares. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Price Performance

ISRG stock opened at $595.55 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a fifty day moving average price of $558.58 and a 200-day moving average price of $518.00. The stock has a market capitalization of $212.12 billion, a P/E ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 over the last quarter. 0.90% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.